Cone Rod Dystrophy Treatment

Dr. Ramesh Bhardwaj D.H.M.S  •  Dr. Puja Bhadel Bhardwaj  M.D.


Cone rod retinal dystrophy characteristically leads to early impairment of vision. An initial loss of color vision and of visual acuity (due to loss of cone function) is followed by night blindness and loss of peripheral visual fields (due to loss of rod function).


Both the cone and rod cells can be affected by genetic mutations - not only the cone cells. Mutations in genetic code undermine the functioning of protective rhodopsin pigment in the rods. As rod cells deteriorate then the user has increasing difficulty seeing:




gradual loss of night vision

gradual loss of peripheral vision

sensitivity to bright light

vision is best at dusk

errors in color vision in both red-green and blue-yellow ranges


In young children:

Parents may notice Nystagmus, which are rapid movements of the eyes back and forth from side to side, and/or

their child`s eyes appearing to slowly wander around not focused upon any object, and/or

the child touching her eyes with her fingers as though she were poking them.

Parents will often notice these signs by the way the child acts.



Most cone rod dystrophies are genetically based and result from "misprints" in a child`s genes, and are typically carried forward from the parents` genes although sometimes by chance a new mistake occurs in the child`s genes and the parents` genes are normal.




There is no known cure for cone rod dystrophy, although homoeopathic medicine is showing promising vectors that may replace damaged muscle tissue. Treatment is generally aimed at controlling the onset of symptoms to maximize the quality of life, prevent further detoriation leading to gradual improvement in vision of patients.


One can notice symptomatic improvement within 3-4 months of treatment. Duration of treatment varies with the severity of disease. We have documented up to 80% improvement in our patients.